Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02470312 · ClinicalTrials.gov registry record
MediGuide Registry
A clinical trial, sponsored by Abbott Medical Devices.
- Terminated
- Registry status
- 578
- Enrollment target
NCT02470312: Clinical Trial study, sponsored by Abbott Medical Devices.
NCT02470312 is a clinical trial that was terminated before completion, run by Abbott Medical Devices. The registered enrollment target is 578 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02470312 was terminated before completion, sponsored by Abbott Medical Devices.
- TERMINATED
- Registry status
- 578 participants
- Enrollment target
Study Summary
The goal of this registry/observational study is to collect data on the clinical utility of MediGuide™ system in cardiac resynchronization therapy (CRT) implantation and electrophysiology (EP) procedures.
Primary Outcome
Amount of fluoroscopy time during CRT implant or EP procedure
Interventions
- PROCEDURE CRT implantation
- DEVICE MediGuide
- PROCEDURE EP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 578 participants |
| Start Date | 2015-08-18 |
| Est. Completion | 2018-02-28 |
Why NCT02470312 stopped before completion
NCT02470312 is an observational study that tracks outcomes without assigning an intervention. The registered 578 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 3 interventions - of which CRT implantation is the first listed.
NCT02470312 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02470312 about?
NCT02470312 is a clinical study titled "MediGuide Registry". The goal of this registry/observational study is to collect data on the clinical utility of MediGuide™ system in cardiac resynchronization therapy (CRT) implantation and electrophysiology (EP) procedures.
What is the current status of trial NCT02470312?
This trial is currently terminated. The enrollment target is 578 participants. The study started on 2015-08-18. Estimated completion is 2018-02-28.
What interventions are being tested in trial NCT02470312?
The interventions under investigation include: CRT implantation (PROCEDURE), MediGuide (DEVICE), EP (PROCEDURE).
Who is sponsoring clinical trial NCT02470312?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07290543 · 578 participants · NA
Web-Based Toolkit to Improve Cancer-Related Emotional Distress and Anxiety in Rural Older Cancer Survivors
- NCT04575935 · 580 participants · Phase 3
Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial
- NCT05143177 · 580 participants · Phase 2
A Study to Evaluate the Efficacy and Safety of DA-1229 (Evogliptin) in Patient's Calcific Aortic Valve Disease With Mild to Moderate Aortic Stenosis (EVOID-AS)
- NCT05696353 · 580 participants · Phase 3
Teen Driving Translation Study (NIH)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI